GT Biopharma IncQ) expected to post a loss of 68 cents a share - Earnings Preview

Reuters
2025.08.08 12:53
portai
I'm PortAI, I can summarize articles.

GT Biopharma IncQ) is expected to report a loss of 68 cents per share for the period ending June 30, 2025, with results anticipated on August 12. The mean earnings estimate has remained unchanged over the last three months, and the only analyst rating is a "buy." Wall Street's median 12-month price target for the company is $11.00, representing an 83.4% increase from its last closing price of $1.83.

  • GT Biopharma Inc (GTBP.OQ) (GTBP.O) is expected to report resultson August 12 (estimated) for the period ending June 30 2025
  • ​LSEG’s mean analyst estimate for GT Biopharma Inc is for a loss of 68 cents per share.
  • The one available analyst rating on the shares is “buy”.
  • The mean earnings estimate of analysts was unchanged in the last three months. ​
  • Wall Street’s median 12-month price target for GT Biopharma Inc is $11.00, about 83.4% above its last closing price of $1.83 This summary was machine generated August 8 at 12:53 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.